Anti-doping Control in the Third Millennium: No more "invisible" substances?;I Controlli antidoping nel Terzo Millennio: Mai più sostanze "invisibili"?

Medicina dello Sport

Volumn 60, Issue 2, 2007, Pages 119-131

  Botre F ^a,b,c,d  

^a Laboratorio Antidoping FMSI   (Italy)

^b WAADS (World Association of Anti Doping Scientists)   (Italy)

^c Comitato Per I Laboratori Accreditati dell'Agenzia Mondiale Antidoping ^*  (Italy)

^d Italian National Olympic Committee   (Italy)

Author keywords

Doping; Sport

Indexed keywords

BETA ADRENERGIC RECEPTOR BLOCKING AGENT; BETA ADRENERGIC RECEPTOR STIMULATING AGENT; DIURETIC AGENT; ERYTHROPOIETIN; GLUCOCORTICOID; NARCOTIC AGENT; NOVEL ERYTHROPOIESIS STIMULATING PROTEIN; SIBUTRAMINE; STEROID;

ACCREDITATION; CLINICAL PRACTICE; DOPING; DRUG EFFICACY; HEALTH CARE ORGANIZATION; HEALTH CARE PERSONNEL; HEALTH PROGRAM; HEALTH SERVICE; LABORATORY; MEDICAL INFORMATION; PRACTICE GUIDELINE; REVIEW; SCREENING TEST; SPORTS MEDICINE;

EID: 34547699272     PISSN: 00257826     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Review

References (18)

1. Legge 14 dicembre 2000, n. 376. Disciplina della tutela sanitaria delle attività sportive e della lotta contro il doping- Gazzetta Ufficiale della Repubblica Italiana, Serie Generale, Anno 141, Numero 294 del 18.12.2000.
2. The World Anti-Doping Code. The 2007 Prohibited List International Standard. World Anti-Doping Agency, Montreal (Canada), 2007 (disponibile on-line all'indirizzo web www.wada-ama.org/rtecontent/document/ 2007_List_En.pdf)
3. Botrè F. Drugs of abuse and abuse of drugs in sportsmen: the role of in vitro methods to study effect and mechanism. Toxicol. In Vitro, 2003;17:509-13.
4. Mazzarino M, Botrè F. A fast liquid chromatographic/mass spectrometric screening method for the simultaneous detection of synthetic glucocorticoids, some stimulants, anti-oestrogen drugs and synthetic anabolic steroids" Rapid Commun Mass Spectrom 2006;20:3465-76.
5. Thevis M, Sigmund G, Schiffer AK, Schanzer W. Determination of N-desmethyl- and N-bisdesmethyl metabolites of Sibutramine in doping control analysis using liquid chromatography-tandem mass spectrometry". Eur J Mass Spectrom 2006;12:129-36.
6. Strano Rossi S, Colamonici C, Botrè F. Detection of sibutramine administration: a gas chromatography/mass spectrometry study of the main urinary metabolites. Rapid Commun Mass Spectrom 2007;21:79-88.
7. Catlin DH, Sekera MH, Ahrens BD, Starcevic B, Chang YC, Hatton CK. Tetrahydrogestrinone: discovery, synthesis, and detection in urine. Rapid Commun Mass Spectrom 2004;18:1245-9-
8. Sekera MH, Ahrens BD, Chang YC, Starcevic B, Georgakopoulos C, Catlin DH. Another designer steroid: discovery, synthesis, and detection of 'madol' in urine". Rapid Commun Mass Spectrom 2005;19:781-4.
9. Amendola L, Molaioni F, Botrè F. Detection of beta-blockers in human urine by GC-MS-MS-EI: perspectives for the antidoping control" J Pharm Biomed Anal 2000;23:211-21.
10. Mazzarino M, Braganò MC, Botrè F. An LC/MS-MS screening method for synthetic glucocorticoids based on pharmacological structure-activity relationships. In: Schänzer W, Geyer A, Gotzman A, Mareck U, editors. Recent advances in doping analysis (14). Köln: Sportverlag Straub, 2006.p.17-25.
11. Thevis M, Kamber M, Schanzer W. Screening for metabolically stable aryl-propionamide-derived selective androgen receptor modulators for doping control purposes. Rapid Commun Mass Spectrom 2006;20: 870-6.
12. Aguilera R, Becchi M, Casabianca H, Hatton CK, Catlin DH, Starcevic B et al. Improved method of detection of testosterone abuse by gas chromatography/combustion/isotope ratio mass spectrometry analysis of urinary steroids. J Mass Spectrom 1996;31: 169-76.
13. Lasne F, Martin L, Crepin N, de Ceaurriz J. Detection of isoelectric profiles of erythropoietin in urine: differentiation of natural and administered recombinant hormones. Anal Biochem 2002;311:119-26.
14. Bidlingmaier M, Wu Z, Strasburger CJ. Problems with GH doping in sports. J Endocrinol Invest 2003;26: 924-31.
15. Thevis M, Thomas A, Delahaut P, Bosseloir A, Schaenzer W. Doping control analysis of intact rapid-acting insulin analogues in hhuman urine by liquid chromatography-tandem mass spectrometry. Anal Chem 2006;78:1897-903.
16. Thomas A, Thevis M, Delahaut P, Bosseloir A, Schaenzer W. Mass spectrometric identification of degradation products of insulin and its long-acting analogues in human urine for doping control purposes. Anal Chem 2007;79:2518-24.
17. Sharpe K, Ashenden M, Schumacher YO. A third generation approach to detect erythropoietin abuse in athletes" Haematologica 2006;91:356-63.
18. McHugh CM, Park RT, Sonksen PH, Holt RI. Challenges in detecting the abuse of growth hormone in sport. Clin Chem 2005;51:1587-93.